Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The Coretec Group will have limited evaluation samples of Cyclohexasilane in early 2021!
Dec 02, 2020
"Due to demand for Phase 1 evaluation samples, The Coretec Group has now begun the pre-sale of CHS to Phase 2 evaluators."
https://www.thecoretecgroup.com/media/coretec-blog/detail/1444/the-coretec-group-will-have-limited-evaluation-samples-of
TWA,
Hopefully this will clear up the uncertainty you have concerning CRTG IP patent protection.
This is verbatim from the CEO blog: Coretec updates CHS manufacturing progress, patent filing and next steps
Mar 12, 2020
Laying the groundwork for a full patent filing
Coretec has secured a non-public provisional patent on CHS manufacturing, which protects our IP and planned commercialization process for CHS for a full calendar year.
Our team has worked to develop and refine the specific claims we want to include in the full patent filing, which will protect CHS and its process from competitors, and are finalizing its filing to meet the upcoming deadline. Meanwhile, Coretec has and will continue to have, protectable IP in CHS manufacturing as well as in applications that utilize CHS to improve performance such as solar, LED, battery and printable electronics.
https://www.thecoretecgroup.com/media/coretec-blog/detail/1386/coretec-updates-chs-manufacturing-progress-patent-filing
This is verbatim from the CEO on page 11 of 12 from the The Coretec Group Shareholder Update Call July 22, 2020 10:00 AM ET
Michael Kraft
"Exactly. Thank you, Ken, very much for that explanation. There's a couple other questions here about patents. The first question is, “has the patent been fully issued?” Well, it hasn't been issued because it's in process. There's two that we're doing, I don't know which one is being referenced here but, in the case of the CHS manufacturing, or synthesis, it has been a full patent application as of March of 2020. Unfortunately, it takes two or three years for patent examiners to get back to the filing person, the filing company. So, March of 2020, add two years, plus maybe a little bit, and we'll hear from the patent examiner. That review can typically take months, sometimes six to 18 months. So, my guess is, our goal would be having that patent for CHS synthesis granted sometime in about two to three years from now. That's very typical, by the way.
The other question related to patents was, will our technology infringe on the NDSU patents? Well, I'm not the patent examiner, but, I'm very familiar with the NDSU patents we had licensed in the past. I'm also one of the co-inventors of the patent we filed for CHS synthesis. So, this is what I'll say, I don't believe it's going to infringe at all. It is a different chemical synthesis process."
https://d1io3yog0oux5.cloudfront.net/thecoretecgroup/files/pages/thecoretecgroup/db/171/post_event_details/Coretec+July+22nd+Shareholder+Update+Call_final+2020+07+27.pdf
Quikshft,
Well articulated and to the point, appreciate your due diligence.
Quikshft, I remember that run TDCP had back in May of 2011. Thanks for sharing your thoughts on Coretec and the potential of CHS adoption into a manufacturing process and resultant contract sales. I share your optimism and believe we will be well rewarded in the not too distant future.
Quikshft,
I remain hopeful that CRTG will make significant in roads to contracts and revenue in 2021. Respectfully request your thoughts on this.
CRTG stock price will rise as we get contracts and revenue. Granted this will take time. However, as CHS becomes ubiquitous, in the various demand markets via the "different chemical synthesis process", the pps will rise significantly.
The minimum requirements to list on the NASDAQ are as follows:
The Nasdaq has four sets of listing requirements. Each company must meet at least one of the four requirement sets, as well as the main rules for all companies.1?
Listing Requirements for All Companies
Each company must have a minimum of 1,250,000 publicly traded shares upon listing, excluding those held by officers, directors or any beneficial owners of more than 10% of the company.
Also, the regular bid price at the time of listing must be $4.00, and there must be at least three market makers for the stock.
However, a company may qualify under a closing price alternative of $3.00 or $2.00 if the company meets varying requirements.
Each listing firm is also required to follow NASDAQ corporate governance rules 4350, 4351 and 4360.
Companies must also have at least 450 round lot (100 shares) shareholders, 2,200 total shareholders, or 550 total shareholders with 1.1 million average trading volume over the past 12 months.
Latest CRTG blog: Cyclohexasilane as a Higher Order Silane
https://www.thecoretecgroup.com/media/coretec-blog/detail/1443/cyclohexasilane-as-a-higher-order-silane
CRTG will secure contracts and manufacture CHS silicon
PATENT ATTORNEY:
Your original provisional patent application will expire after one year and you will have to file a new provisional application or simply file a non-provisional application, however, your provisional application filing date will have lapsed. There might possibly be a route available by petition, but if there is, it is usually only extended for 1-2 months beyond the one year - after that, your original provisional application is dead if you have not filed a non-provisional or PCT application.
An overview of a patent application and maintenance process
https://www.uspto.gov/patents-getting-started/patent-process-overview#step1
As the CEO stated:
"It is a different chemical synthesis process."
Pegs1
This is verbatim from the CEO on page 11 of 12 from the The Coretec Group Shareholder Update Call July 22, 2020 10:00 AM ET
Michael Kraft
"Exactly. Thank you, Ken, very much for that explanation. There's a couple other questions here about patents. The first question is, “has the patent been fully issued?” Well, it hasn't been issued because it's in process. There's two that we're doing, I don't know which one is being referenced here but, in the case of the CHS manufacturing, or synthesis, it has been a full patent application as of March of 2020. Unfortunately, it takes two or three years for patent examiners to get back to the filing person, the filing company. So, March of 2020, add two years, plus maybe a little bit, and we'll hear from the patent examiner. That review can typically take months, sometimes six to 18 months. So, my guess is, our goal would be having that patent for CHS synthesis granted sometime in about two to three years from now. That's very typical, by the way.
The other question related to patents was, will our technology infringe on the NDSU patents? Well, I'm not the patent examiner, but, I'm very familiar with the NDSU patents we had licensed in the past. I'm also one of the co-inventors of the patent we filed for CHS synthesis. So, this is what I'll say, I don't believe it's going to infringe at all. It is a different chemical synthesis process."
https://d1io3yog0oux5.cloudfront.net/thecoretecgroup/files/pages/thecoretecgroup/db/171/post_event_details/Coretec+July+22nd+Shareholder+Update+Call_final+2020+07+27.pdf
Review of “Electronic Specialty Gases” conference, hosted by Linx Consulting
Nov 16, 2020
By Michelle Tokarz
https://www.thecoretecgroup.com/media/coretec-blog/detail/1442/review-of-electronic-specialty-gases-conference
I believe there will not be a RS. 3DICON had two RS prior to merging with CRTG because they had no other way to fund operations after encountering issues with development of the glass enclosure for the image space.The 35 to 1 RS that 3DICON initiated back in 2016 to merge with Coretec eliminated several investors who chose not to buy more shares afterwards. CRTG is ready to bring CHS to customers that want to supply several potential lucrative markets. CHS is scalable and will bring CRTG to the forefront in taking Lithium Ion battery technology to the next level. The IP for CHS is protected by the provisional patent that was filed in March 2020. The final patent approval will probably not occur until July 2023. Michael Kraft specifically addressed that process in the shareholder meeting notes from July 22, 2020. Ken Evans mentioned that CRTG would be moving up to the OTCBB and he sees a path to the NASDAQ now that CRTG is poised to move forward with CHS in the latest shareholder meeting notes.
The push is on to transition over to Electric Vehicle transportation, which bodes well for CHS demand in the future.
Newsom orders ban of new gas-powered cars by 2035
https://calmatters.org/environment/2020/09/california-ban-gasoline-powered-cars-in-2035/
UK to Ban Sale of New Gasoline, Diesel Cars From 2030: FT
https://www.theepochtimes.com/uk-to-ban-sale-of-new-petrol-and-diesel-cars-from-2030-ft_3579820.html
Latest CEO update
Value of Liquid Precursors and Low Temperature Depositions
https://www.thecoretecgroup.com/media/coretec-blog/detail/1441/value-of-liquid-precursors-and-low-temperature-depositions
November 12, 2020 Quarterly report pursuant to Section 13 or 15(d)
https://ir.thecoretecgroup.com/all-sec-filings/content/0001437749-20-023535/0001437749-20-023535.pdf
Yes he does, and the potential applications for CHS continue to grow!
Another post on CEO blog released later today
https://www.thecoretecgroup.com/media/coretec-blog/detail/1436/silicon-nanowires-as-a-cost-competitive-replacement-to
Link to Coretec Shareholder Letter
https://www.thecoretecgroup.com/media/press-releases/detail/1354/the-coretec-group-releases-shareholder-letter-highlighting
Some highlights:
"First, the supply partnership we entered into with Evonik just a few months ago is on schedule to deliver the initial 50g CHS samples by January 2021
Through our partnership with Evonik and manufacturing in Germany, we can supply CHS worldwide with an initial focus on the USA and Europe where a majority of our customer interest, design, and product development efforts originate.
Second, we continue to take steps to acquire customers and establish partnerships. We have received significant interest from numerous customers in core markets spanning semiconductor, silicon anode Li Ion battery, and LED. I am especially pleased to have announced the partnership with Theion, where CHS is a key material in creating a battery that will enable faster EV adoption.
Finally, we just announced that we will be, once again, trading on the OTCQB venture market, a premier market for entrepreneurial and development stage U.S. and international companies that are committed to providing investors with high-quality trading and improved market visibility."
CRTG has agreements and partnerships that will develop into a thriving business, producing great products and revenue
Yes it is. The stock price will rise as we get contracts and revenue.
The minimum requirements to list on the NASDAQ are as follows:
The Nasdaq has four sets of listing requirements. Each company must meet at least one of the four requirement sets, as well as the main rules for all companies.1?
Listing Requirements for All Companies
Each company must have a minimum of 1,250,000 publicly traded shares upon listing, excluding those held by officers, directors or any beneficial owners of more than 10% of the company.
Also, the regular bid price at the time of listing must be $4.00, and there must be at least three market makers for the stock.
However, a company may qualify under a closing price alternative of $3.00 or $2.00 if the company meets varying requirements.
Each listing firm is also required to follow NASDAQ corporate governance rules 4350, 4351 and 4360.
Companies must also have at least 450 round lot (100 shares) shareholders, 2,200 total shareholders, or 550 total shareholders with 1.1 million average trading volume over the past 12 months.
The Coretec Group Announces Upgrade to OTCQB Venture Market
https://www.thecoretecgroup.com/media/press-releases/detail/1353/the-coretec-group-announces-upgrade-to-otcqb-venture-market
The Coretec Group Shareholder Update Call July 22, 2020 10:00 AM ET
Ken Evans
Sure, Michael, happy to. Yes, we are on the pinks now, however, we are in the process of completing and providing to the OTC markets our application to move onto the OTC:QB. There are three tiers in the OTC markets, and QB is the second. It confirms that we are a fully reporting '34 Act company, that we're filing all of our required reports on a timely basis.
And more importantly it provides additional market-makers, who are willing to follow the company and get involved. It also provides additional credibility for the future as we look to the capital markets to raise additional financing. It puts us on the path, basically, combined with the other things that the team are accomplishing with regard to the commercialization of CHS, it puts us on a pathway to NASDAQ, which is where we would really like to be. Though, you know, the path to NASDAQ takes time, and will require some financial engineering, but it's attainable now, and that hasn't been able to be thought about before because of the steps and the progress that we're making on the commercialization. So, we hope that will be a very positive move to QB and will be a very positive thing for the company. We hope all of you listening go away with positive feelings about the company and go buy some stock.
I concur and believe more good news is forthcoming soon
Coretec established a strategic partnership with Theion, a battery technology company based in Berlin, Germany.
https://www.thecoretecgroup.com/media/press-releases/detail/1352/the-coretec-group-announces-strategic-partnership-with
Tesla Needs Silicon Anodes to Increase Battery Performance
https://www.thecoretecgroup.com/media/coretec-blog/detail/1432/tesla-needs-silicon-anodes-to-increase-battery-performance
Link to the Michigan Innovation headquarters Sept 24th video with Coretec at the 28:30 minute mark
https://mi-hq.com/tech-on-the-edge
Luck is for rabbits...we've all read the 8K filed in June and the 10Q filed in August. The point is Coretec has an agreement with Evonik to supply CHS to identified customers by the end of the year. It's just semantics on whether the terminology is partnership, or agreement.
FFF,
You wrote "pegs1, when did a major chemical company partner with CRTG?"
The press release on July 8, 2020 used the term Manufacturing Partnership in the title and supply partnership in the first paragraph. It sounds like a partnership to me.
https://www.accesswire.com/596578/The-Coretec-Group-Secures-Manufacturing-Partnership-with-Evonik-Industries
Manufacturing partnership with Evonik
https://www.thecoretecgroup.com/media/coretec-blog/detail/1416/coretecs-manufacturing-partnership-with-evonik
Are we approaching the Tipping Point? Time will tell.
https://www.thecoretecgroup.com/media/coretec-blog/detail/1429/an-investment-in-materials-for-a-sustainable-future
True, but I think the specific advantages of CHS were all addressed and presented effectively in layman's terms. The answers and explanations to the questions asked were all fielded well. There are always advantages to presenting technical information in person, but a virtual, video briefing, with excellent slides, is still effective in communicating with the target audience.
Check out the Virtual Presentation given by Ramez E. for the Battery Show 2020
https://www.thecoretecgroup.com/media/webinars/detail/1426/the-battery-show-2020---chs-for-silicon-anodes
None on the Closed Space Project, but I believe CHS will hit pay dirt prior to CS
Noticed this paragraph in the CEO Blog from Jan 10, 2020:
Customer & Partner Proximity
One of the most important draws to this area is the potential for partnerships with companies and customers. There are a number of companies currently focused on semiconductor development and mobility applications that are based within and around the city. Forming strategic partnerships is key to company growth and success, and with companies such as KLA Tencor, Renesas, Wacker, and Google in the area, we see significant potential and opportunity to work more closely with these companies and their applications.
KLA Tencor is heavily involved with Chip manufacturing and located in Ann Arbor, MI.
Renesas provides a comprehensive lineup of semiconductor devices and easy-to-use, sophisticated microcontroller development environments. They are located in Farmington Mills, MI just 32 miles to the northeast of Ann Arbor, MI
Wacker Chemical is located in Adrian, MI just 31 miles to the southwest of Ann Arbor, MI They are heavily involved with Silanes as the starting point and chief building blocks of silicone production. Pioneering European silicone production, WACKER started to manufacture silanes in 1950. They are produced in WACKER’s integrated production system via direct synthesis from silicon and methyl chloride (Müller-Rochow synthesis). Silicates are then made from tetrafunctional silanes.
Google is in Ann Arbor, MI and also Detroit, MI working the Waymo self driving car project 43 miles to the east of Ann Arbor, MI
I believe the Coretec move to Ann Arbor has placed the CEO and future employees right in the middle of potential engineering talent and CHS commercialization.
I'm excited about the future of Coretec. Start up ventures are hi risk, but with hi risk come break throughs and great rewards. The leadership continues to file the 10Qs with the SEC and I believe are doing their best to get CHS to market. Time will tell!